<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Chlamydia trachomatis infections in the newborn</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Chlamydia trachomatis infections in the newborn</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Chlamydia trachomatis infections in the newborn</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Margaret R Hammerschlag, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 11, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span><em>Chlamydia</em> <em>trachomatis</em> is the most common bacterial sexually transmitted infection in the United States. Infants born vaginally to infected mothers with genital disease are at risk for acquiring <em>C</em>. <em>trachomatis</em>, which usually presents as conjunctivitis and/or pneumonia [<a href="#rid1">1</a>].</p><p>The clinical features, diagnosis, and treatment of <em>C</em>. <em>trachomatis</em> conjunctivitis and pneumonia in the newborn and young infant are reviewed here.</p><p>Pneumonia in older children, other disorders caused by <em>C</em>. <em>trachomatis</em> or <em>Chlamydia</em> <em>pneumoniae</em>, and the possible role of infection in preterm delivery are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/5957.html" rel="external">"Pneumonia caused by <i>Chlamydia pneumoniae</i> in children"</a> and  <a class="medical medical_review" href="/z/d/html/6021.html" rel="external">"Acute otitis media in children: Epidemiology, microbiology, and complications"</a> and  <a class="medical medical_review" href="/z/d/html/6761.html" rel="external">"Spontaneous preterm birth: Overview of risk factors and prognosis"</a>.)</p><p class="headingAnchor" id="H2589495681"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span>There are 15 serotypes of <em>C</em>. <em>trachomatis</em>. Neonatal infection is usually caused by <em>C</em>. <em>trachomatis</em> serotypes D through K, which are the primary serotypes causing genital disease in adults [<a href="#rid2">2</a>]. The microbiology of <em>C</em>. <em>trachomatis</em> is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/89490.html" rel="external">"Epidemiology of <i>Chlamydia trachomatis</i> infections", section on 'Microbiology'</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY AND TRANSMISSION</span><span class="headingEndMark"> — </span><em>C</em>. <em>trachomatis</em> is primarily transmitted to newborns via exposure to an infected mother's genital flora during vaginal birth [<a href="#rid3">3</a>]. The implementation of routine screening and treatment of pregnant women has dramatically reduced the incidence of perinatally acquired <em>C</em>. <em>trachomatis</em> infection in the United States.</p><p class="headingAnchor" id="H3"><span class="h2">Prevalence in pregnancy</span><span class="headingEndMark"> — </span>The following is a brief review of the prevalence of <em>C</em>. <em>trachomatis</em> in pregnant women. The prevalence and risk factors for <em>C</em>. <em>trachomatis</em> infection in women in the general population are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/89490.html" rel="external">"Epidemiology of <i>Chlamydia trachomatis</i> infections"</a>.)</p><p>The prevalence of <em>C</em>. <em>trachomatis</em> in pregnant women ranges from 2 to 20 percent depending on the population screened [<a href="#rid2">2,4,5</a>]. Similar to the increased prevalence of <em>C</em>. <em>trachomatis</em> in adolescent and young adult women in the general population, the highest prevalence rate in pregnancy occurs in adolescent and young adult women. This was illustrated in a British study that screened 1216 pregnant women for <em>C</em>. <em>trachomatis</em> infection by testing for the presence of the organism by ligase chain reaction from self-administered vaginal swab or first-pass urine specimens [<a href="#rid6">6</a>]. The overall prevalence of infection was 2.4 percent. In women less than 25 years of age and adolescents, the prevalence increased to 8.6 and 14.3 percent, respectively. In another study of 203 pregnant adolescents from the United States, 18 percent had <em>C</em>. <em>trachomatis</em> infection in the third trimester of pregnancy [<a href="#rid7">7</a>].</p><p>Although not specifically studied in pregnant women, other risk factors for <em>C</em>. <em>trachomatis</em> infection in sexually active women include multiple sex partners, non-use of barrier contraceptives, concurrent or prior sexually transmitted disease, and anatomic factors (eg, cervical friability or cervical ectopy). Presumably, these risk factors for <em>C</em>. <em>trachomatis</em> infection seen in the general population are also likely to be risk factors for infection in pregnant women. (See  <a class="medical medical_review" href="/z/d/html/89490.html" rel="external">"Epidemiology of <i>Chlamydia trachomatis</i> infections"</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Risk of transmission</span><span class="headingEndMark"> — </span>The risk of acquiring <em>C</em>. <em>trachomatis</em> in an infant born vaginally to a woman with chlamydial cervicitis is approximately 50 percent but has been reported to be as high as 60 to 70 percent [<a href="#rid4">4,5,8-14</a>]. However, this estimation includes newborns with asymptomatic infection of the nasopharynx or only serologic evidence of infection. The rate of symptomatic chlamydial infection in infants born to <em>C</em>. <em>trachomatis</em>-infected mothers is lower. Based upon positive cultures for <em>C</em>. <em>trachomatis</em> in symptomatic infants, the risk for neonatal-acquired conjunctivitis is between 20 and 50 percent and, for pneumonia, between 5 and 30 percent [<a href="#rid2">2,8-10,13,14</a>].</p><p>The discrepancy of transmission rate based upon detection methods and location of screening in at-risk infants is best illustrated by a prospective study of 5531 pregnant women [<a href="#rid8">8</a>]. Positive cervical cultures for <em>C</em>. <em>trachomatis</em> were detected in 262 women (4.7 percent), and 131 of their infants were followed prospectively. Sixty percent of these infants demonstrated positive serology for <em>C</em>. <em>trachomatis</em>, and, in 36 percent of infants, the organism was isolated from cultures of the nasopharynx, conjunctivae, rectum, and vagina. Culture-positive conjunctivitis was diagnosed in 23 of these 131 infants (18 percent) and pneumonia in 21 (16 percent). Rectal and vaginal colonization was demonstrated in 14 percent. However, the anti-<em>C</em>. <em>trachomatis</em> antibody was probably maternal in origin and did not represent infection [<a href="#rid15">15</a>].</p><p>While vaginal birth carries the highest risk of transmission, there is a small risk of acquiring infections in infants born by cesarean delivery both with premature rupture of membranes and intact membranes [<a href="#rid3">3,16-19</a>]. In one study of 141 exposed infants, for example, <em>C</em>. <em>trachomatis</em> was isolated from 58 of 125 infants delivered vaginally, 2 of 10 delivered by cesarean delivery with rupture of membranes, and 1 of 6 delivered by cesarean delivery without rupture of membranes [<a href="#rid3">3</a>]. The latter condition indicates either a transmembrane or a transplacental transmission of the infection.</p><p class="headingAnchor" id="H5"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H6"><span class="h2">Conjunctivitis</span><span class="headingEndMark"> — </span>The most frequent clinical manifestation of <em>C</em>. <em>trachomatis</em> infection in the newborn is conjunctivitis. The condition is sometimes referred to as inclusion conjunctivitis of the newborn or inclusion blennorrhea.</p><p>The incubation period for <em>C</em>. <em>trachomatis</em> conjunctivitis is 5 to 14 days after delivery. Presentation before five days is unusual but has been reported to occur earlier in infants born to mothers with premature rupture of the membranes [<a href="#rid20">20</a>].</p><p>Clinical findings of conjunctivitis range from mild swelling with a watery eye discharge, which becomes mucopurulent (<a class="graphic graphic_picture graphicRef74760" href="/z/d/graphic/74760.html" rel="external">picture 1</a>), to marked swelling of the eyelids with red and thickened conjunctivae (chemosis). A pseudomembrane may form as the exudate adheres to conjunctiva. The conjunctivae may also be very friable, resulting in bloody discharge. In a retrospective study of 90 infants from Hong Kong with conjunctivitis, bloodstained eye discharge was found to have high specificity and positive predictive value for chlamydial conjunctivitis [<a href="#rid21">21</a>]. A membrane of granulation tissue (micropannus) may form, especially if the patient is untreated for more than two weeks [<a href="#rid22">22</a>].</p><p>Treatment of conjunctivitis usually results in healing without complications. However, untreated infection may persist for months and cause corneal and conjunctival scarring [<a href="#rid23">23-25</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Pneumonia</span><span class="headingEndMark"> — </span>Among infants born to mothers with cervical <em>C</em>. <em>trachomatis</em> infection, 5 to 30 percent develop pneumonia [<a href="#rid8">8-10,13,14</a>]. Approximately one-half of these infants have a history of conjunctivitis.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing of presentation</strong> – Pneumonia due to <em>C</em>. <em>trachomatis</em> is recognized in most affected infants between 4 and 12 weeks of age, although essentially all are symptomatic before eight weeks [<a href="#rid20">20</a>]. Some infants may have upper respiratory tract symptoms as early as two weeks of age. <em>C</em>. <em>trachomatis</em> has been isolated from tracheal secretions of preterm infants with pneumonia diagnosed in the first week after birth [<a href="#rid26">26,27</a>]. Affected infants may have prolonged duration of symptoms. In one report, the mean duration of symptoms prior to admission was eight days [<a href="#rid28">28</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Signs and symptoms</strong> – Cough and nasal congestion without significant discharge are common, although occasional infants may have thick nasal secretions [<a href="#rid29">29</a>]. Patients usually are afebrile or have minimal fever. Characteristic features are a staccato cough that may occur in paroxysms, as well as tachypnea, although these are not universally present [<a href="#rid2">2</a>]. Preterm infants may have apneic spells associated with the infection. Rales are often present on auscultation of the lungs; wheezing is uncommon. The liver and spleen may be easily palpable because of the hyperinflated lungs [<a href="#rid30">30</a>]. Mild to moderate hypoxemia may be noted [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/z/d/html/5048.html" rel="external">"Management of apnea of prematurity"</a> and  <a class="medical medical_review" href="/z/d/html/4987.html" rel="external">"Bronchopulmonary dysplasia (BPD): Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Laboratory and radiographic findings</strong> – Peripheral eosinophilia is a characteristic laboratory finding; however, the total white blood cell count is typically normal [<a href="#rid28">28,30</a>].</p><p></p><p class="bulletIndent1">The chest radiograph typically shows hyperinflation with bilateral, symmetrical interstitial infiltrates (<a class="graphic graphic_diagnosticimage graphicRef119451" href="/z/d/graphic/119451.html" rel="external">image 1</a>) [<a href="#rid30">30</a>].</p><p></p><p class="headingAnchor" id="H9"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>Nucleic acid amplification tests (NAATs) are considered the gold standard for diagnosis of chlamydial infections. They have high sensitivity and specificity for detection of <em>C</em>. <em>trachomatis</em> in conjunctival or nasopharyngeal specimens [<a href="#rid31">31,32</a>], although they have not yet been cleared by the US Food and Drug Administration (FDA) for use in this setting. Several NAATs were approved by the FDA in 2019 for use in extragenital sites (pharynx and rectum) in adults. Laboratories do internal validation for use of NAATs for conjunctival and nasopharyngeal swabs.</p><p><em>Chlamydia</em> culture previously was considered the gold standard for diagnosis; however, culture is more labor intensive and expensive and has largely been replaced by NAATs.</p><p class="headingAnchor" id="H10"><span class="h2">Indications for testing</span><span class="headingEndMark"> — </span><em>C</em>. <em>trachomatis</em> should be suspected in an infant less than one month of age with conjunctivitis if there is the possibility of exposure to the organism, specifically if the mother has a history of untreated <em>C</em>. <em>trachomatis</em> infection or no prenatal care. If there has been no prenatal care or a maternal history of <em>Neisseria</em> <em>gonorrhoeae</em>, the exudate also should be examined with Gram stain and cultured using selective medium to detect <em>N</em>. <em>gonorrhoeae</em>. (See  <a class="medical medical_review" href="/z/d/html/4983.html" rel="external">"Gonococcal infection in the newborn"</a>.)</p><p>The diagnosis of <em>C</em>. <em>trachomatis</em> infection should be considered in an infant less than three months of age with pneumonia if the mother has a history of untreated infection or no prenatal care.</p><p class="headingAnchor" id="H11"><span class="h2">Specimens</span><span class="headingEndMark"> — </span>Newborns suspected of chlamydial infection should have both conjunctival and nasopharyngeal samples taken.</p><p>Conjunctival specimens for <em>C</em>. <em>trachomatis</em> testing should be obtained by swabbing the everted eyelid using aluminum-shafted Dacron-tipped swab or a swab specified by the manufacturer's test kit. The specimens must include conjunctival epithelial cells because <em>C</em>. <em>trachomatis</em> is an obligate intracellular organism. Exudates are not adequate for testing.</p><p>Respiratory specimens for <em>C</em>. <em>trachomatis</em> testing should be obtained from the nasopharynx. Tracheal aspirates can be sent in patients who are intubated.</p><p class="headingAnchor" id="H12"><span class="h2">Diagnostic methods</span></p><p class="headingAnchor" id="H14"><span class="h3">Nucleic acid amplification tests</span><span class="headingEndMark"> — </span>NAATs are considered the gold standard for diagnosing neonatal chlamydial infections. NAAT methodology consists of amplifying <em>C</em>. <em>trachomatis</em> DNA or RNA sequences. Studies investigating the performance of NAATs in the setting of genital and extragenital (pharynx, rectum) infections in sexually active men and women have found that, compared with culture, NAATs have higher sensitivity and comparable specificity [<a href="#rid33">33-36</a>]. There are six commercially available NAAT assays for detection of <em>C</em>. <em>trachomatis</em> that are approved by the FDA, though none is approved specifically for use in conjunctival or nasopharyngeal specimens from infants [<a href="#rid34">34</a>]. Infants with <em>C</em>. <em>trachomatis</em> conjunctivitis usually have very high numbers of organisms present, and it is easy to obtain an adequate specimen. As a result, it seems likely that NAATs will perform well in this setting and the available data support this [<a href="#rid31">31,32</a>].</p><p>Most NAATs are laboratory based, and results are typically not immediately available [<a href="#rid35">35,36</a>]. (See  <a class="medical medical_review" href="/z/d/html/83019.html" rel="external">"Clinical manifestations and diagnosis of <i>Chlamydia trachomatis </i>infections", section on 'Rapid tests for chlamydia'</a>.)</p><p class="headingAnchor" id="H2283835034"><span class="h3">Culture</span><span class="headingEndMark"> — </span><em>Chlamydia</em> culture, performed in tissue culture, is a sensitive and specific method for detection of neonatal chlamydial infections; however, it is labor intensive and expensive and has largely been replaced by NAATs.</p><p class="headingAnchor" id="H189497872"><span class="h2">Testing for Neisseria gonorrhoeae</span><span class="headingEndMark"> — </span>A diagnosis of <em>C</em>. <em>trachomatis</em> in a neonate should prompt evaluation for possible <em>N</em>. <em>gonorrhoeae</em> infection [<a href="#rid2">2</a>]. Treatment for <em>N</em>. <em>gonorrhoeae</em> is indicated only if testing is positive. (See  <a class="medical medical_review" href="/z/d/html/4983.html" rel="external">"Gonococcal infection in the newborn"</a>.)</p><p class="headingAnchor" id="H17"><span class="h1">TREATMENT</span></p><p class="headingAnchor" id="H4122940213"><span class="h2">When to initiate</span><span class="headingEndMark"> — </span>The decision of when to initiate treatment depends on the type of infection:</p><p class="bulletIndent1"><span class="glyph">●</span>Conjunctivitis – Initial treatment for chlamydial conjunctivitis should be based upon a positive diagnostic test.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pneumonia – Initial therapy for chlamydial pneumonia is empiric until diagnostic test results are available [<a href="#rid33">33</a>]. A presumptive diagnosis is based upon characteristic clinical and radiographic findings, particularly in an infant born to a mother with a chlamydial infection that was not adequately treated prenatally. Other features that help distinguish chlamydial pneumonia from other respiratory infections in newborns and thus may prompt consideration of diagnostic testing and empiric treatment include conjunctivitis (either prior to or concurrent with respiratory symptoms), protracted illness, staccato cough, eosinophilia, and bilateral interstitial infiltrates on chest radiograph (<a class="graphic graphic_diagnosticimage graphicRef119451" href="/z/d/graphic/119451.html" rel="external">image 1</a>).</p><p></p><p class="headingAnchor" id="H18"><span class="h2">Choice of antibiotic</span><span class="headingEndMark"> — </span>Oral <a class="drug drug_pediatric" data-topicid="12937" href="/z/d/drug information/12937.html" rel="external">azithromycin</a> is the preferred treatment for neonatal <em>C</em>. <em>trachomatis</em> infections, including both conjunctivitis and pneumonia [<a href="#rid33">33</a>]. The dosing regimen is the same for both indications: 20 mg/kg per day given orally once daily for three days [<a href="#rid2">2</a>]. <a class="drug drug_pediatric" data-topicid="13276" href="/z/d/drug information/13276.html" rel="external">Erythromycin</a> base, 50 mg/kg/day in four divided doses for 14 days, is an alternative.</p><p>Data on the effectiveness of <a class="drug drug_pediatric" data-topicid="12937" href="/z/d/drug information/12937.html" rel="external">azithromycin</a> in treating <em>C</em>. <em>trachomatis</em> infections in infants are limited [<a href="#rid37">37,38</a>]. In a case series of 13 infants with <em>C</em>. <em>trachomatis</em> conjunctivitis, three of five infants treated with single dose of azithromycin therapy became culture negative with resolution of symptoms [<a href="#rid38">38</a>]. Of the eight infants treated once daily for three days, six had resolution of symptoms with negative cultures, one had improved symptoms though cultures remained positive until <a class="drug drug_pediatric" data-topicid="13276" href="/z/d/drug information/13276.html" rel="external">erythromycin</a> was given, and one, was lost to follow-up.</p><p>Topical therapy for chlamydial conjunctivitis is <strong>not</strong> effective, and there is a high failure rate compared with oral therapy in eradicating conjunctival infection; topical therapy also does not eradicate nasopharyngeal infection [<a href="#rid2">2,9,39</a>]. This was illustrated in a randomized controlled study of infants with chlamydial conjunctivitis that reported eradication of the organism in 14 of 15 patients treated with oral <a class="drug drug_pediatric" data-topicid="13276" href="/z/d/drug information/13276.html" rel="external">erythromycin</a> versus persistent conjunctival infection in eight infants and nasopharyngeal colonization in 3 of 14 infants treated with topical ointment [<a href="#rid39">39</a>]. These results demonstrate that oral compared with topical erythromycin provides better resolution of conjunctivitis and eradication of <em>C</em>. <em>trachomatis</em> from the nasopharynx.</p><p class="headingAnchor" id="H19"><span class="h2">Risk of pyloric stenosis</span><span class="headingEndMark"> — </span>Both <a class="drug drug_pediatric" data-topicid="12937" href="/z/d/drug information/12937.html" rel="external">azithromycin</a> and <a class="drug drug_pediatric" data-topicid="13276" href="/z/d/drug information/13276.html" rel="external">erythromycin</a> are associated with increased risk of infantile hypertrophic pyloric stenosis (IHPS), particularly in infants younger than two weeks [<a href="#rid40">40</a>]. Parents should be advised about the potential risk for IHPS, and infants should be observed closely for signs of intestinal obstruction. (See  <a class="medical medical_review" href="/z/d/html/5890.html" rel="external">"Infantile hypertrophic pyloric stenosis", section on 'Macrolide antibiotics'</a>.)</p><p class="headingAnchor" id="H20"><span class="h2">Treatment of the mother</span><span class="headingEndMark"> — </span>The infant's mother and her sexual partner(s) should be evaluated and treated for <em>C</em>. <em>trachomatis</em> infection. They also should be evaluated for other sexually transmitted diseases. (See  <a class="medical medical_review" href="/z/d/html/7579.html" rel="external">"Treatment of <i>Chlamydia trachomatis</i> infection"</a>.)</p><p class="headingAnchor" id="H21"><span class="h1">PREVENTION</span></p><p class="headingAnchor" id="H22"><span class="h2">Maternal screening</span><span class="headingEndMark"> — </span>Routine screening for chlamydial infection is recommended by the United States Preventive Services Task Force for all pregnant women &lt;25 years of age and women ≥25 years of age with risk factors for sexually transmitted infection (<a class="graphic graphic_table graphicRef112388" href="/z/d/graphic/112388.html" rel="external">table 1</a>) [<a href="#rid33">33,41</a>]. Routine screening and treatment during pregnancy has resulted in a dramatic decrease in perinatal chlamydial infections in the United States. (See <a class="local">'Epidemiology and transmission'</a> above.)</p><p>In countries where prenatal screening is not routinely offered (eg, the Netherlands, China), perinatally transmitted <em>C</em>. <em>trachomatis</em> remains a common cause of neonatal conjunctivitis and respiratory illness in those regions [<a href="#rid42">42-45</a>]. In a study from Rotterdam, <em>C</em>. <em>trachomatis</em> was responsible for approximately 64 percent of the cases of neonatal conjunctivitis seen in a large university-affiliated hospital from 1999 through 2001 [<a href="#rid42">42</a>]. In another study from the same institution, respiratory <em>C</em>. <em>trachomatis</em> infection was confirmed in 7 percent of infants &lt;6 months of age presenting with respiratory complaints [<a href="#rid45">45</a>].</p><p>Screening for chlamydial infections during pregnancy is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/446.html" rel="external">"Prenatal care: Initial assessment", section on 'Chlamydia'</a>.)</p><p class="headingAnchor" id="H23"><span class="h2">Prophylaxis against conjunctivitis</span><span class="headingEndMark"> — </span>In the United States, neonatal prophylaxis against gonococcal conjunctivitis is routinely performed at birth. However, neonatal ocular prophylaxis is not effective in preventing neonatal chlamydial conjunctivitis [<a href="#rid46">46-51</a>]. The diagnosis and treatment of chlamydial infections in pregnant women is the best method for preventing chlamydial disease. In Canada, the practice of routine neonatal ocular prophylaxis is no longer recommended and the emphasis has shifted to enhanced maternal screening [<a href="#rid52">52</a>]. (See  <a class="medical medical_review" href="/z/d/html/446.html" rel="external">"Prenatal care: Initial assessment", section on 'Chlamydia'</a>.)</p><p>Prophylaxis for gonococcal conjunctivitis is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/5068.html" rel="external">"Overview of the routine management of the healthy newborn infant", section on 'Eye care'</a> and  <a class="medical medical_review" href="/z/d/html/4983.html" rel="external">"Gonococcal infection in the newborn", section on 'Ophthalmia neonatorum'</a>.)</p><p class="headingAnchor" id="H24"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transmission</strong> – Infants who are born vaginally to mothers with untreated genital <em>Chlamydia</em> <em>trachomatis</em> infection are at risk for developing <em>C</em>. <em>trachomatis</em> conjunctivitis (15 to 50 percent) and/or pneumonia (5 to 20 percent). (See <a class="local">'Epidemiology and transmission'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Neonatal <em>C</em>. <em>trachomatis</em> infection can present with (see <a class="local">'Clinical manifestations'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Conjunctivitis</strong> – The most common clinical manifestation of neonatal <em>C</em>. <em>trachomatis</em> infection is conjunctivitis, which usually presents between 5 and 14 days of life. Symptoms range from mild swelling with a watery eye discharge, which becomes mucopurulent (<a class="graphic graphic_picture graphicRef74760" href="/z/d/graphic/74760.html" rel="external">picture 1</a>), to marked swelling of the eyelids with red and thickened conjunctivae (chemosis). Untreated infants may have persistent conjunctivitis for months that may result in corneal and conjunctival scarring. (See <a class="local">'Conjunctivitis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pneumonia</strong> – Neonatal <em>C</em>. <em>trachomatis</em> pneumonia presents between 4 and 12 weeks of age, although most infants are symptomatic before eight weeks (<a class="graphic graphic_diagnosticimage graphicRef119451" href="/z/d/graphic/119451.html" rel="external">image 1</a>). Patients are usually afebrile or have minimal fever with a staccato cough. Many infants also have conjunctivitis. Apnea may be seen in infected preterm infants. (See <a class="local">'Pneumonia'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – Nucleic acid amplification tests (NAATs) have high sensitivity and specificity for detection of <em>C</em>. <em>trachomatis</em> and are considered the gold standard for diagnosis. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – Our approach to treating <em>C</em>. <em>trachomatis</em> infections in neonates is as follows (see <a class="local">'Treatment'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>When to initiate therapy</strong> – For neonates with conjunctivitis, the decision to initiate treatment is based on a positive diagnostic test. Initial therapy for chlamydial pneumonia is empiric until diagnostic test results are available. A presumptive diagnosis is based upon characteristic clinical and radiographic findings, particularly in an infant born to a mother with a chlamydial infection that was not adequately treated prenatally. (See <a class="local">'When to initiate'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Choice of antibiotic</strong> – For neonates with <em>C</em>. <em>trachomatis</em> infections, including conjunctivitis or pneumonia, we suggest a course of oral <a class="drug drug_pediatric" data-topicid="12937" href="/z/d/drug information/12937.html" rel="external">azithromycin</a> rather than other agents (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Azithromycin is given orally at a dose of 20 mg/kg once daily for three days. Topical therapy is <strong>not</strong> effective for <em>C</em>. <em>trachomatis</em> conjunctivitis and is unnecessary if the patient is treated systemically. (See <a class="local">'Choice of antibiotic'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevention</strong> – The most effective way to prevent perinatal chlamydial infection is through a systematic program that identifies and treats all pregnant women with genital <em>C</em>. <em>trachomatis</em> infection. The recommended topical therapies for preventing neonatal gonococcal conjunctivitis are <strong>not</strong> effective for preventing chlamydial conjunctivitis. (See <a class="local">'Prevention'</a> above.)</p><p></p><p class="headingAnchor" id="H372426372"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Mohan Pammi, MD, PhD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Herieka E, Dhar J. Acute neonatal respiratory failure and Chlamydia trachomatis. Sex Transm Infect 2001; 77:135.</a></li><li class="breakAll">American Academy of Pediatrics. Chlamydia trachomatis. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd Ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), Red Book: 2021-2024 Report of the Committee on Infectious Diseases, Itasca, IL 2021.</li><li><a class="nounderline abstract_t">Bell TA, Stamm WE, Kuo CC, et al. Risk of perinatal transmission of Chlamydia trachomatis by mode of delivery. J Infect 1994; 29:165.</a></li><li><a class="nounderline abstract_t">FitzSimmons J, Callahan C, Shanahan B, Jungkind D. Chlamydial infections in pregnancy. J Reprod Med 1986; 31:19.</a></li><li><a class="nounderline abstract_t">Much DH, Yeh SY. Prevalence of Chlamydia trachomatis infection in pregnant patients. Public Health Rep 1991; 106:490.</a></li><li><a class="nounderline abstract_t">Oakeshott P, Hay P, Hay S, et al. Association between bacterial vaginosis or chlamydial infection and miscarriage before 16 weeks' gestation: prospective community based cohort study. BMJ 2002; 325:1334.</a></li><li><a class="nounderline abstract_t">Niccolai LM, Ethier KA, Kershaw TS, et al. Pregnant adolescents at risk: sexual behaviors and sexually transmitted disease prevalence. Am J Obstet Gynecol 2003; 188:63.</a></li><li><a class="nounderline abstract_t">Schachter J, Grossman M, Sweet RL, et al. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA 1986; 255:3374.</a></li><li><a class="nounderline abstract_t">Hammerschlag MR, Chandler JW, Alexander ER, et al. Longitudinal studies on chlamydial infections in the first year of life. Pediatr Infect Dis 1982; 1:395.</a></li><li><a class="nounderline abstract_t">Frommell GT, Rothenberg R, Wang S, McIntosh K. Chlamydial infection of mothers and their infants. J Pediatr 1979; 95:28.</a></li><li><a class="nounderline abstract_t">Hammerschlag MR, Anderka M, Semine DZ, et al. Prospective study of maternal and infantile infection with Chlamydia trachomatis. Pediatrics 1979; 64:142.</a></li><li><a class="nounderline abstract_t">Chandler JW, Alexander ER, Pheiffer TA, et al. Ophthalmia neonatorum associated with maternal chlamydial infections. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1977; 83:302.</a></li><li><a class="nounderline abstract_t">Heggie AD, Lumicao GG, Stuart LA, Gyves MT. Chlamydia trachomatis infection in mothers and infants. A prospective study. Am J Dis Child 1981; 135:507.</a></li><li><a class="nounderline abstract_t">Rosenman MB, Mahon BE, Downs SM, Kleiman MB. Oral erythromycin prophylaxis vs watchful waiting in caring for newborns exposed to Chlamydia trachomatis. Arch Pediatr Adolesc Med 2003; 157:565.</a></li><li><a class="nounderline abstract_t">Banniettis N, Wisecup K, Boland L, et al. Association of Routine Chlamydia trachomatis Screening During Pregnancy and Seroprevalence of Chlamydial Infection in Children, 1991-2015. J Pediatric Infect Dis Soc 2021; 10:172.</a></li><li><a class="nounderline abstract_t">Shariat H, Young M, Abedin M. An interesting case presentation: a possible new route for perinatal acquisition of Chlamydia. J Perinatol 1992; 12:300.</a></li><li><a class="nounderline abstract_t">Bell TA. Chlamydia trachomatis infection in dizygotic twins delivered by caesarean section. Genitourin Med 1988; 64:347.</a></li><li><a class="nounderline abstract_t">Mårdh PA, Johansson PJ, Svenningsen N. Intrauterine lung infection with Chlamydia trachomatis in a premature infant. Acta Paediatr Scand 1984; 73:569.</a></li><li><a class="nounderline abstract_t">Givner LB, Rennels MB, Woodward CL, Huang SW. Chlamydia trachomatis infection in infant delivered by cesarean section. Pediatrics 1981; 68:420.</a></li><li class="breakAll">Hammerschlag MR, Kohlhoff SA. Chlamydia infections. In: Textbook of Pediatric Infectious Diseases, 8th ed, Feigin RD, Cherry J, Demmler-Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ (Eds), WB Saunders, Philadelphia 2018. p.1952.</li><li><a class="nounderline abstract_t">Mordhorst CH, Dawson C. Sequelae of neonatal inclusion conjunctivitis and associated disease in parents. Am J Ophthalmol 1971; 71:861.</a></li><li><a class="nounderline abstract_t">Weinstock H, Dean D, Bolan G. Chlamydia trachomatis infections. Infect Dis Clin North Am 1994; 8:797.</a></li><li><a class="nounderline abstract_t">Goscienski PJ, Sexton RR. Follow-up studies in neonatal inclusion conjunctivitis. Am J Dis Child 1972; 124:180.</a></li><li><a class="nounderline abstract_t">Forster RK, Dawson CR, Schachter J. Late follow-up of patients with neonatal inclusion conjunctivitis. Am J Ophthalmol 1970; 69:467.</a></li><li><a class="nounderline abstract_t">Shinkwin CA, Gibbin KP. Neonatal upper airway obstruction caused by chlamydial rhinitis. J Laryngol Otol 1995; 109:58.</a></li><li><a class="nounderline abstract_t">Sollecito D, Midulla M, Bavastrelli M, et al. Chlamydia trachomatis in neonatal respiratory distress of very preterm babies: biphasic clinical picture. Acta Paediatr 1992; 81:788.</a></li><li><a class="nounderline abstract_t">Colarizi P, Chiesa C, Pacifico L, et al. Chlamydia trachomatis-associated respiratory disease in the very early neonatal period. Acta Paediatr 1996; 85:991.</a></li><li><a class="nounderline abstract_t">Chen CJ, Wu KG, Tang RB, et al. Characteristics of Chlamydia trachomatis infection in hospitalized infants with lower respiratory tract infection. J Microbiol Immunol Infect 2007; 40:255.</a></li><li><a class="nounderline abstract_t">Tipple MA, Beem MO, Saxon EM. Clinical characteristics of the afebrile pneumonia associated with Chlamydia trachomatis infection in infants less than 6 months of age. Pediatrics 1979; 63:192.</a></li><li><a class="nounderline abstract_t">Attenburrow AA, Barker CM. Chlamydial pneumonia in the low birthweight neonate. Arch Dis Child 1985; 60:1169.</a></li><li><a class="nounderline abstract_t">Hammerschlag MR, Roblin PM, Gelling M, et al. Use of polymerase chain reaction for the detection of Chlamydia trachomatis in ocular and nasopharyngeal specimens from infants with conjunctivitis. Pediatr Infect Dis J 1997; 16:293.</a></li><li><a class="nounderline abstract_t">Yip PP, Chan WH, Yip KT, et al. The use of polymerase chain reaction assay versus conventional methods in detecting neonatal chlamydial conjunctivitis. J Pediatr Ophthalmol Strabismus 2008; 45:234.</a></li><li><a class="nounderline abstract_t">Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021; 70:1.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. MMWR Recomm Rep 2014; 63:1.</a></li><li><a class="nounderline abstract_t">Meyer T. Diagnostic Procedures to Detect Chlamydia trachomatis Infections. Microorganisms 2016; 4.</a></li><li><a class="nounderline abstract_t">Nwokolo NC, Dragovic B, Patel S, et al. 2015 UK national guideline for the management of infection with Chlamydia trachomatis. Int J STD AIDS 2016; 27:251.</a></li><li><a class="nounderline abstract_t">Beem MO, Saxon E, Tipple MA. Treatment of chlamydial pneumonia of infancy. Pediatrics 1979; 63:198.</a></li><li><a class="nounderline abstract_t">Hammerschlag MR, Gelling M, Roblin PM, et al. Treatment of neonatal chlamydial conjunctivitis with azithromycin. Pediatr Infect Dis J 1998; 17:1049.</a></li><li><a class="nounderline abstract_t">Heggie AD, Jaffe AC, Stuart LA, et al. Topical sulfacetamide vs oral erythromycin for neonatal chlamydial conjunctivitis. Am J Dis Child 1985; 139:564.</a></li><li><a class="nounderline abstract_t">Eberly MD, Eide MB, Thompson JL, Nylund CM. Azithromycin in early infancy and pyloric stenosis. Pediatrics 2015; 135:483.</a></li><li><a class="nounderline abstract_t">LeFevre ML, U.S. Preventive Services Task Force. Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014; 161:902.</a></li><li><a class="nounderline abstract_t">Rours IG, Hammerschlag MR, Ott A, et al. Chlamydia trachomatis as a cause of neonatal conjunctivitis in Dutch infants. Pediatrics 2008; 121:e321.</a></li><li><a class="nounderline abstract_t">Wu SX, Yang J, Liu G. A clinical study in China of neonatal conjunctivitis caused by Chlamydia trachomatis. Clin Pediatr (Phila) 2003; 42:83.</a></li><li><a class="nounderline abstract_t">Jain S. Perinatally acquired Chlamydia trachomatis associated morbidity in young infants. J Matern Fetal Med 1999; 8:130.</a></li><li><a class="nounderline abstract_t">Rours GI, Hammerschlag MR, Van Doornum GJ, et al. Chlamydia trachomatis respiratory infection in Dutch infants. Arch Dis Child 2009; 94:705.</a></li><li><a class="nounderline abstract_t">Darville T. Chlamydia trachomatis infections in neonates and young children. Semin Pediatr Infect Dis 2005; 16:235.</a></li><li><a class="nounderline abstract_t">Chen JY. Prophylaxis of ophthalmia neonatorum: comparison of silver nitrate, tetracycline, erythromycin and no prophylaxis. Pediatr Infect Dis J 1992; 11:1026.</a></li><li class="breakAll">American Academy of Pediatrics. Gonococcal infections. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32nd Ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021.</li><li><a class="nounderline abstract_t">Bell TA, Sandström KI, Gravett MG, et al. Comparison of ophthalmic silver nitrate solution and erythromycin ointment for prevention of natally acquired Chlamydia trachomatis. Sex Transm Dis 1987; 14:195.</a></li><li><a class="nounderline abstract_t">Isenberg SJ, Apt L, Wood M. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. N Engl J Med 1995; 332:562.</a></li><li><a class="nounderline abstract_t">Chang K, Cheng VY, Kwong NS. Neonatal haemorrhagic conjunctivitis: a specific sign of chlamydial infection. Hong Kong Med J 2006; 12:27.</a></li><li class="breakAll">Canadian Paediatric Society Position Statement: Preventing ophthalmia neonatorum. Available at: https://www.cps.ca/en/documents/position/ophthalmia-neonatorum (Accessed on November 15, 2018).</li></ol></div><div id="topicVersionRevision">Topic 4993 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11287694" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Acute neonatal respiratory failure and Chlamydia trachomatis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11287694" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Acute neonatal respiratory failure and Chlamydia trachomatis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7806879" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Risk of perinatal transmission of Chlamydia trachomatis by mode of delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3950876" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Chlamydial infections in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1910182" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Prevalence of Chlamydia trachomatis infection in pregnant patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12468483" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Association between bacterial vaginosis or chlamydial infection and miscarriage before 16 weeks' gestation: prospective community based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12548197" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pregnant adolescents at risk: sexual behaviors and sexually transmitted disease prevalence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3712696" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Prospective study of perinatal transmission of Chlamydia trachomatis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7163029" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Longitudinal studies on chlamydial infections in the first year of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/480010" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Chlamydial infection of mothers and their infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/471604" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Prospective study of maternal and infantile infection with Chlamydia trachomatis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/878139" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Ophthalmia neonatorum associated with maternal chlamydial infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7234783" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Chlamydia trachomatis infection in mothers and infants. A prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12796237" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Oral erythromycin prophylaxis vs watchful waiting in caring for newborns exposed to Chlamydia trachomatis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31958120" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Association of Routine Chlamydia trachomatis Screening During Pregnancy and Seroprevalence of Chlamydial Infection in Children, 1991-2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1432291" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : An interesting case presentation: a possible new route for perinatal acquisition of Chlamydia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3203935" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Chlamydia trachomatis infection in dizygotic twins delivered by caesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6464746" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Intrauterine lung infection with Chlamydia trachomatis in a premature infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7279471" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Chlamydia trachomatis infection in infant delivered by cesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7279471" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Chlamydia trachomatis infection in infant delivered by cesarean section.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4928532" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Sequelae of neonatal inclusion conjunctivitis and associated disease in parents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7890933" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Chlamydia trachomatis infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5052404" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Follow-up studies in neonatal inclusion conjunctivitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4190799" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Late follow-up of patients with neonatal inclusion conjunctivitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7876741" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Neonatal upper airway obstruction caused by chlamydial rhinitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1421884" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Chlamydia trachomatis in neonatal respiratory distress of very preterm babies: biphasic clinical picture.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8863885" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Chlamydia trachomatis-associated respiratory disease in the very early neonatal period.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17639167" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Characteristics of Chlamydia trachomatis infection in hospitalized infants with lower respiratory tract infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/440806" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Clinical characteristics of the afebrile pneumonia associated with Chlamydia trachomatis infection in infants less than 6 months of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4091583" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Chlamydial pneumonia in the low birthweight neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9076818" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Use of polymerase chain reaction for the detection of Chlamydia trachomatis in ocular and nasopharyngeal specimens from infants with conjunctivitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18705621" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The use of polymerase chain reaction assay versus conventional methods in detecting neonatal chlamydial conjunctivitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34292926" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Sexually Transmitted Infections Treatment Guidelines, 2021.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24622331" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27681919" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Diagnostic Procedures to Detect Chlamydia trachomatis Infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26538553" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : 2015 UK national guideline for the management of infection with Chlamydia trachomatis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/440807" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Treatment of chlamydial pneumonia of infancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9849993" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Treatment of neonatal chlamydial conjunctivitis with azithromycin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3890519" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Topical sulfacetamide vs oral erythromycin for neonatal chlamydial conjunctivitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25687145" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Azithromycin in early infancy and pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25243785" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18245405" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Chlamydia trachomatis as a cause of neonatal conjunctivitis in Dutch infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12635988" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A clinical study in China of neonatal conjunctivitis caused by Chlamydia trachomatis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10338068" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Perinatally acquired Chlamydia trachomatis associated morbidity in young infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19395401" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Chlamydia trachomatis respiratory infection in Dutch infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16210104" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Chlamydia trachomatis infections in neonates and young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1461692" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Prophylaxis of ophthalmia neonatorum: comparison of silver nitrate, tetracycline, erythromycin and no prophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1461692" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Prophylaxis of ophthalmia neonatorum: comparison of silver nitrate, tetracycline, erythromycin and no prophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3438783" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Comparison of ophthalmic silver nitrate solution and erythromycin ointment for prevention of natally acquired Chlamydia trachomatis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7838190" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16495586" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Neonatal haemorrhagic conjunctivitis: a specific sign of chlamydial infection.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
